These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2971497)

  • 1. Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease.
    Nagel JS; Johnson KA; Ichise M; English RJ; Walshe TM; Morris JH; Holman BL
    Clin Nucl Med; 1988 Jul; 13(7):486-90. PubMed ID: 2971497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caudate nucleus infarction demonstrated by N-isopropyl-p iodoamphetamine SPECT imaging using a rotating gamma camera.
    Polak JF; Mueller SP; Holman BL
    Clin Nucl Med; 1986 Oct; 11(10):718-20. PubMed ID: 3490342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?
    Wardlaw JM; Sellar RJ; Abernethy LJ
    Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans.
    Nagel JS; Ichise M; Holman BL
    Semin Nucl Med; 1991 Jan; 21(1):11-23. PubMed ID: 1825359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single photon emission computed tomography (SPECT) with N-isopropyl-p-(123I) iodoamphetamine in partial epilepsy--evaluation of delayed image].
    Kawamura M; Murase K; Mogami H; Kataoka M; Itoh H; Tanada S; Iio A; Hamamoto K; Hatakeyama T; Kimura H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):630-42. PubMed ID: 2508057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A
    J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-isopropyl(I-123)p-iodoamphetamine brain scans with single-photon emission tomography: discordance with transmission computed tomography.
    Lee RG; Hill TC; Holman BL; Clouse ME
    Radiology; 1982 Dec; 145(3):795-9. PubMed ID: 6983089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iofetamine HCl I-123 (Iodoamphetamine) brain SPECT atlas.
    Falls M; Park CH; Madsen M
    Clin Nucl Med; 1985 Jun; 10(6):443-9. PubMed ID: 3874740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional cerebral blood flow images of single photon emission computed tomography by N-isopropyl-p-[I-123] iodoamphetamine in patients with brain tumor].
    Hashimoto K; Kikuchi H; Yamagata S; Naruo Y; Koizumi T; Nishimura T; Hayasida K; Hayashi M; Karasawa J
    No To Shinkei; 1987 Jul; 39(7):687-93. PubMed ID: 3499919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [N-isopropyl-p-(I-123)iodoamphetamine (I-123 IMP) SPECT I-123 IMP SPECT in patients with intracranial tumor].
    Nakano S; Hasegawa Y; Ibuka K; Hashizume T; Noguchi A; Nakagawa H; Taki T; Nii Y
    Kaku Igaku; 1987 Nov; 24(11):1701-7. PubMed ID: 3502283
    [No Abstract]   [Full Text] [Related]  

  • 12. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophy of caudate nucleus in Huntington's disease measured by computed tomography.
    Roth J; Havrdová E; Růzicka E
    J Neurol; 2000 Nov; 247(11):880-1. PubMed ID: 11151423
    [No Abstract]   [Full Text] [Related]  

  • 14. External evaluation of a deep learning-based approach for automated brain volumetry in patients with huntington's disease.
    Haase R; Lehnen NC; Schmeel FC; Deike K; Rüber T; Radbruch A; Paech D
    Sci Rep; 2024 Apr; 14(1):9243. PubMed ID: 38649395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two patients with meningioma visualized as high uptake by SPECT with N-isopropyl-p-iodo-amphetamine (I-123).
    Nishimura T; Hayashida K; Uehara T; Imakita S; Hashimoto K; Naruo Y; Kikuchi H
    Neuroradiology; 1988; 30(4):351-4. PubMed ID: 3262837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of language and neurologic recovery after cerebral infarction with SPECT imaging using N-isopropyl-p-(I 123) iodoamphetamine.
    Bushnell DL; Gupta S; Mlcoch AG; Barnes WE
    Arch Neurol; 1989 Jun; 46(6):665-9. PubMed ID: 2786406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-isopropyl I-123 p-iodoamphetamine single photon emission computed tomography of herpes simplex encephalitis].
    Ito K; Sone S; Kondo Y; Nakanishi F; Kasuga T; Kondo K; Kagoshima M; Miyata Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Oct; 49(10):1290-7. PubMed ID: 2616262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical study of auditory hallucination by single photon emission computed tomography (SPECT) using N-isopropyl-p-[123I] iodoamphetamine (IMP)].
    Gyobu T; Matsuda H; Hisada K; Inao G; Ii M
    Seishin Shinkeigaku Zasshi; 1988; 90(4):334-58. PubMed ID: 3261874
    [No Abstract]   [Full Text] [Related]  

  • 20. Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.
    Künig G; Leenders KL; Sanchez-Pernaute R; Antonini A; Vontobel P; Verhagen A; Günther I
    Ann Neurol; 2000 May; 47(5):644-8. PubMed ID: 10805336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.